M3 Biotechnology

M3 Biotechnology

M3 Biotechnology

M3 is a biopharmaceutical company focused on development of therapeutics to address Alzheimer's, Parkinson's and Neurodegeneration.
Type
B2c
Raised
$26.6M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$1,400,000
Undisclosed funding - 2017
Alzheimer's Drug Discovery Foundation
Team Size
1–10
Employees
GeekWire

Working Geek: M3 Biotechnology CEO Leen Kawas on shifting from academia to startups

Robotics People
$1,400,000 Undisclosed funding
GeekWire

M3 Biotechnology gets another $1.4M in funding, prepares to start clinical trials of leading drug candidate

Health
$10,000,000 Undisclosed
GeekWire

Seattle-drug startup M3Biotechnology closes $10 million funding round

Funding Health